The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
Open accessAbstract
After its discovery in the early 1980s, the natriuretic peptide (NP) system has been extensively characterized and its potential influence in the development and progression of heart failure (HF) has been investigated. HF is a syndrome characterized by the activation of different neurohormonal systems, predominantly the renin-angiotensin (Ang)-aldosterone system (RAAS) and the sympathetic nervous system (SNS), but also the NP system. Pharmacological interventions have been developed to counteract the neuroendocrine dysregulation, through the down modulation of RAAS with ACE (Ang-converting enzyme) inhibitors, ARBs (Ang receptor blockers) and mineralcorticoid antagonists and of SNS with β-blockers. In the last years, growing attention has been paid to the NP system. In the present review, we have summarized the current knowledge on the NP system, focusing on its role in HF and we provide an overview of the pharmacological attempts to modulate NP in HF: from the negative results of the study with neprilysin (NEP) inhibitors, alone or associated with an ACE inhibitor and vasopeptidase inhibitors, to the most recently and extremely encouraging results obtained with the new pharmacological class of Ang receptor and NEP inhibitor, currently defined ARNI (Ang receptor NEP inhibitor). Indeed, this new class of drugs to manage HF, supported by the recent results and a vast clinical development programme, may prompt a conceptual shift in the treatment of HF, moving from the inhibition of RAAS and SNS to a more integrated target to rebalance neurohormonal dysregulation in HF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
de Bold, A. J., Borenstein, H. B., Veress, A. T., & Sonnenberg, H. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90370-2 · Cited by 3,148
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
Boudoulas, K. D., Borer, J. S., & Boudoulas, H. (2015) · Cardiology · doi:10.1159/000435947 · Cited by 1,938
Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,889
Green, C. P., Porter, C. B., Bresnahan, D. R., & Spertus, J. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00531-3 · Cited by 1,827
A new natriuretic peptide in porcine brain
Sudoh, T., Kangawa, K., Minamino, N., & Matsuo, H. (1988) · Nature · doi:10.1038/332078a0 · Cited by 1,816
Granger, C. B., McMurray, J. J., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., Östergren, J., Pfeffer, M. A., & Swedberg, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14284-5 · Cited by 1,686
Pitt, B., Segal, R., Martinez, F. A., Meurers, G., Cowley, A. J., Thomas, I., Deedwania, P. C., Ney, D. E., Snavely, D. B., & Chang, P. I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,665
Flather, M. D., Yusuf, S., Køber, L., Pfeffer, M., Hall, A., Murray, G., Torp-Pedersen, C., Ball, S., Pogue, J., Moyé, L., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02212-1 · Cited by 1,585
Hjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Francis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,388
Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., & Yasue, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115146 · Cited by 1,354
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
O'Connor, C. M., Starling, R. C., Hernandez, A. F., Armstrong, P. W., Dickstein, K., Hasselblad, V., Heizer, G. M., Komajda, M., Massie, B. M., McMurray, J. J. V., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100171 · Cited by 1,252
Solomon, S. D., Zile, M., Pieske, B., Voors, A., Shah, A., Kraigher-Krainer, E., Shi, V., Bransford, T., Takeuchi, M., Gong, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61227-6 · Cited by 1,173
Cyclic Nucleotide-Gated Ion Channels
Kaupp, U. B., & Seifert, R. (2002) · Physiological Reviews · doi:10.1152/physrev.00008.2002 · Cited by 1,143
Sudoh, T., Minamino, N., Kangawa, K., & Matsuo, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92401-k · Cited by 1,101
Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE
McMurray, J. J. V., Abraham, W. T., Dickstein, K., Køber, L., Massie, B. M., & Krum, H. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs033 · Cited by 1,096
McMurray, J. J. V., Östergren, J., Swedberg, K. B., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer (2003) · The Lancet · Cited by 1,043
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Physiological Role of Silent Receptors of Atrial Natriuretic Factor
Maack, T., Suzuki, M., Almeida, F. A., Nussenzveig, D., Scarborough, R. M., McEnroe, G. A., & Lewicki, J. A. (1987) · Science · doi:10.1126/science.2823385 · Cited by 932
Colucci, W. S., Elkayam, U., Horton, D. P., Abraham, W. T., Bourge, R. C., Johnson, A. D., Wagoner, L. E., Givertz, M. M., Liang, C.-S., Neibaur, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430403 · Cited by 911
Insulin Degradation: Progress and Potential*
Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 871
Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?
Konstantinou, D. M., Karvounis, H., & Giannakoulas, G. (2016) · Cardiology · doi:10.1159/000444078 · Cited by 870
Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.
Roques, B. P., Noble, F., Daugé, V, Fournié-Zaluski, M. C., & Beaumont, A. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00449-1 · Cited by 756
The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties
Flynn, T. G., de Bold, M. L., & de Bold, A. J. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91675-3 · Cited by 736
Braunwald, E. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 730
Plasma bradykinin in angio-oedema
Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09137-x · Cited by 706
Sackner-Bernstein, J. D., Kowalski, M., Fox, M., & Aaronson, K. (2005) · JAMA · doi:10.1001/jama.293.15.1900 · Cited by 693
Packer, M., McMurray, J. J. V., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013748 · Cited by 673
Potter, L. R., Yoder, A. R., Flora, D. R., Antos, L. K., & Dickey, D. M. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-68964-5_15 · Cited by 647
High-affinity enkephalin-degrading peptidase in brain is increased after morphine
MALFROY, B., SWERTS, J. P., GUYON, A., ROQUES, B. P., & SCHWARTZ, J. C. (1978) · Nature · doi:10.1038/276523a0 · Cited by 642
Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J., Rouleau, J.-L., & Swedberg, K. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 621
A placebo-controlled trial of captopril in refractory chronic congestive heart failure
(1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80316-7 · Cited by 589
Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart Failure
Raine, A. E. G., Erne, P., Bürgisser, E., Müller, F. B., Bolli, P., Burkart, F., & Bühler, F. R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150901 · Cited by 585
Cohn, J. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720040031022 · Cited by 582
Chang, M.-S., Lowe, D. G., Lewis, M., Hellmiss, R., Chen, E., & Goeddel, D. V. (1989) · Nature · doi:10.1038/341068a0 · Cited by 581
Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1
Erdös, E. G., & Skidgel, R. A. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.2.2521610 · Cited by 554
Atrial natriuretic peptide: synthesis, release, and metabolism.
Ruskoaho, H. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00456-9 · Cited by 544
Effects of synthetic atrial natriuretic factor on renal function and renin release
Burnett, J. C. J., Granger, J. P., & Opgenorth, T. J. (1984) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1984.247.5.f863 · Cited by 533
Natriuretic peptides: a new lipolytic pathway in human adipocytes
Sengenès, C., Berlan, M., de Glisezinski, I., Lafontan, M., & Galitzky, J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1345 · Cited by 532
Suga, S., Nakao, K., Itoh, H., Komatsu, Y., Ogawa, Y., Hama, N., & Imura, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115933 · Cited by 529
(2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432019 · Cited by 526
Purification and Sequence Analysis of Bioactive Atrial Peptides (Atriopeptins)
Currie, M. G., Geller, D. M., Cole, B. R., Siegel, N. R., Fok, K. F., Adams, S. P., Eubanks, S. R., Galluppi, G. R., & Needleman, P. (1984) · Science · doi:10.1126/science.6419347 · Cited by 523
Atrial Natriuretic Hormone, the Renin–Aldosterone Axis, and Blood Pressure–Electrolyte Homeostasis
Flier, J. S., Underhill, L. H., & Laragh, J. H. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511213132106 · Cited by 519
Gu, J., Noe, A., Chandra, P., Al‐Fayoumi, S., Ligueros‐Saylan, M., Sarangapani, R., Maahs, S., Ksander, G., Rigel, D. F., Jeng, A. Y., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009343932 · Cited by 505
Yan, W., Wu, F., Morser, J., & Wu, Q. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150149097 · Cited by 491
Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995
Haldeman, G. A., Croft, J. B., Giles, W. H., & Rashidee, A. (1999) · American Heart Journal · doi:10.1053/hj.1999.v137.95495 · Cited by 490
Calderone, A., Thaik, C. M., Takahashi, N., Chang, D. L., & Colucci, W. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119883 · Cited by 490
Edwards, B. S., Zimmerman, R. S., Schwab, T. R., Heublein, D. M., & Burnett, J. C. (1988) · Circulation Research · doi:10.1161/01.res.62.2.191 · Cited by 484
The purification and specificity of a neutral endopeptidase from rabbit kidney brush border
Kerr, M. A., & Kenny, A. J. (1974) · Biochemical Journal · doi:10.1042/bj1370477 · Cited by 460
Natriuretic peptide system in human heart failure.
Wei, C. M., Heublein, D. M., Perrella, M. A., Lerman, A., Rodeheffer, R. J., McGregor, C. G., Edwards, W. D., Schaff, H. V., & Burnett, J. C. (1993) · Circulation · doi:10.1161/01.cir.88.3.1004 · Cited by 460
Young, J. B., Dunlap, M. E., Pfeffer, M. A., Probstfield, J. L., Cohen-Solal, A., Dietz, R., Granger, C. B., Hradec, J., Kuch, J., McKelvie, R. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000146819.43235.a9 · Cited by 400
Distinct and specific functions of cGMP-dependent protein kinases
Lohmann, S. M., Vaandrager, A. B., Smolenski, A., Walter, U., & De Jonge, H. R. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01086-4 · Cited by 384
Marin-Grez, M., Fleming, J. T., & Steinhausen, M. (1986) · Nature · doi:10.1038/324473a0 · Cited by 379
Benedict, C. R., Shelton, B., Johnstone, D. E., Francis, G., Greenberg, B., Konstam, M., Probstfield, J. L., & Yusuf, S. (1996) · Circulation · doi:10.1161/01.cir.94.4.690 · Cited by 353
Isolation of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate from rat urine
Ashman, D. F., Lipton, R., Melicow, M. M., & Price, T. D. (1963) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(63)90566-7 · Cited by 341
Schweitz, H., Vigne, P., Moinier, D., Frelin, C., & Lazdunski, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49658-0 · Cited by 334
Shenker, Y., Sider, R. S., Ostafin, E. A., & Grekin, R. J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112154 · Cited by 325
Lerman, A., Gibbons, R. J., Rodeheffer, R. J., Bailey, K. R., McKinley, L. J., Heublein, D. M., & Burnett, J. C. (1993) · The Lancet · doi:10.1016/0140-6736(93)93125-k · Cited by 318
Léan, D., Racz, A., Gutkowska, J., Nguyen, T.-T., Cantin, M., & Genest, J. (1984) · Endocrinology · doi:10.1210/endo-115-4-1636 · Cited by 309
Knowles, J. W., Esposito, G., Mao, L., Hagaman, J. R., Fox, J. E., Smithies, O., Rockman, H. A., & Maeda, N. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11273 · Cited by 302
Kenny, A. J., Bourne, A., & Ingram, J. (1993) · Biochemical Journal · doi:10.1042/bj2910083 · Cited by 293
Harris, P. J., Thomas, D., & Morgan, T. O. (1987) · Nature · doi:10.1038/326697a0 · Cited by 288
Natriuretic peptides in cardiovascular diseases: current use and perspectives
Volpe, M., Rubattu, S., & Burnett, J. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht466 · Cited by 277
Self-citationMangiafico, S., Costello-Boerrigter, L. C., Andersen, I. A., Cataliotti, A., & Burnett, J. C. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs262 · Cited by 276
Kishimoto, I., Rossi, K., & Garbers, D. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051625598 · Cited by 272
A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription.
Grépin, C., Dagnino, L., Robitaille, L., Haberstroh, L., Antakly, T., & Nemer, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3115 · Cited by 272
Sengenès, C., Bouloumié, A., Hauner, H., Berlan, M., Busse, R., Lafontan, M., & Galitzky, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303713200 · Cited by 267
Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man
Yandle, T. G., Richards, A. M., Nicholls, M. G., Cuneo, R., Espiner, E. A., & Livesey, J. H. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90137-2 · Cited by 267
Sharpe, D. N., Murphy, J., Coxon, R., & Hannan, S. F. (1984) · Circulation · doi:10.1161/01.cir.70.2.271 · Cited by 265
Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma
Stingo, A. J., Clavell, A. L., Heublein, D. M., Wei, C., Pittelkow, M. R., & Burnett, J. C. J. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.4.h1318 · Cited by 252
Bradykinin-Mediated Angioedema
Nussberger, J., Cugno, M., & Cicardi, M. (2002) · New England Journal of Medicine · doi:10.1056/nejm200208223470820 · Cited by 232
Furin-mediated Processing of Pro-C-type Natriuretic Peptide
Wu, C., Wu, F., Pan, J., Morser, J., & Wu, Q. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301223200 · Cited by 214
Kangawa, K., Tawaragi, Y., Oikawa, S., Mizuno, A., Sakuragawa, Y., Nakazato, H., Fukuda, A., Minamino, N., & Matsuo, H. (1984) · Nature · doi:10.1038/312152a0 · Cited by 213
EFFECTS OF UK 69 578: A NOVEL ATRIOPEPTIDASE INHIBITOR
Northridge, D., Alabaster, C., Connell, J. C., Dilly, S., Lever, A., Jardine, A., Barclay, P., Dargie, H., Findlay, I., & Samuels, G. R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90714-9 · Cited by 193
Differential regional expression of three natriuretic peptide receptor genes within primate tissues.
Wilcox, J. N., Augustine, A., Goeddel, D. V., & Lowe, D. G. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.7.3454 · Cited by 189
Yamamoto, K., Chappell, M. C., Brosnihan, K. B., & Ferrario, C. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.6.692 · Cited by 189
Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension
Bevan, E. G., Connell, J. M. C., Doyle, J., Carmichael, H. A., Davies, D. L., Lorimer, A. R., & Mclnnes, G. T. (1992) · Journal of Hypertension · doi:10.1097/00004872-199207000-00002 · Cited by 175
Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo
Ura, N., Carretero, O. A., & Erdös, E. G. (1987) · Kidney International · doi:10.1038/ki.1987.239 · Cited by 163
Rubattu, S., Bigatti, G. G. O., Evangelista, A., Lanzani, C. L., Stanzione, R., Zagato, L., Manunta, P., Marchitti, S., Venturelli, V., Bianchi, G., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.081 · Cited by 156
Self-citationNatriuretic peptide-dependent lipolysis in fat cells is a primate specificity
Sengenès, C., Zakaroff‐Girard, A., Moulin, A., Berlan, M., Bouloumié, A., Lafontan, M., & Galitzky, J. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00453.2001 · Cited by 153
Abassi, Z. A., Karram, T., Ellaham, S., Winaver, J. M., & Hoffman, A. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.04.004 · Cited by 151
Richards, M., Wittert, G., Crozier, I., Espiner, E. A., Yandle, T. G., Ikram, H., & Frampton, C. M. (1993) · Journal of Hypertension · doi:10.1097/00004872-199304000-00011 · Cited by 145
Jaagosild, P. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.10.1081 · Cited by 133
Renin–Angiotensin Blockade Combined With Natriuretic Peptide System Augmentation
von Lueder, T. G., Sangaralingham, S. J., Wang, B. H., Kompa, A. R., Atar, D., Burnett, J. C. J., & Krum, H. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000289 · Cited by 131
Witherow, F. N., Helmy, A., Webb, D. J., Fox, K. A. A., & Newby, D. E. (2001) · Circulation · doi:10.1161/hc4301.098252 · Cited by 124
Mechanisms of renal hyporesponsiveness to ANP in heart failure
Charloux, A., Piquard, F., Doutreleau, S., BRANDENBERGER, G., & Gény, B. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01222.x · Cited by 123
Human and canine gene homologs of porcine brain natriuretic peptide
Seilhamer, J. J., Arfsten, A. E., Miller, J. A., Lundquist, P., Scarborough, R. M., Lewicki, J. A., & Porter, J. G. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80015-4 · Cited by 117
Vasopeptidase Inhibition: A Double-Edged Sword?
Campbell, D. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000054215.71691.16 · Cited by 116
Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA
Porter, J. G., Arfsten, A. E., Fuller, F. H., Miller, J., Gregory, L. C., & Lewicki, J. A. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91216-f · Cited by 115
McClean, D. R., Ikram, H., Garlick, A. H., Richards, M., Nicholls, M. G., & Crozier, I. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00741-5 · Cited by 110
Characterization of immunoreactive human C-type natriuretic peptide in brain and heart
Minamino, N., Makino, Y., Tateyama, H., Kangawa, K., & Matsuo, H. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91404-z · Cited by 109
The pharmacokinetics of?-human atrial natriuretic polypeptide in healthy subjects
Nakao, K., Sugawara, A., Morii, N., Sakamoto, M., Yamada, T., Itoh, H., Shiono, S., Saito, Y., Nishimura, K., Ban, T., et al. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00870995 · Cited by 107
Franco, F., Dubois, S. K., Peshock, R. M., & Shohet, R. V. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.2.h679 · Cited by 107
Frantz, S., Klaiber, M., Baba, H. A., Oberwinkler, H., Völker, K., Gaβner, B., Bayer, B., Abeβer, M., Schuh, K., Feil, R., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr445 · Cited by 106
Charles, C. J., Espiner, E. A., Nicholls, M. G., et al. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.2.r373 · Cited by 105
Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase
Smith, M., Espiner, E., Yandle, T. G., Charles, C. J., & Richards, M. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670239 · Cited by 101
Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention.
Francis, G. S., McDonald, K., & Cohn, J. N. (1993) · PubMed · Cited by 100
Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function
Hamad, A. M., Clayton, A., Islam, M. B., & Knox, A. J. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00033.2003 · Cited by 90
Vaidyanathan, S., Valencia, J., Kemp, C. N., Zhao, C. Y., Yeh, C.-M., Bizot, M. N., Denouel, J., Dieterich, H. A., & Dole, W. P. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01164.x · Cited by 87
Zannad, F. M., McMurray, J. J. V., Drexler, H., Krum, H., van Veldhuisen, D. J., Swedberg, K. B., Shi, H. H., Vincent, J., & Pitt, B. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq049 · Cited by 87
Langenickel, T., & Dole, W. P. (2012) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.11.002 · Cited by 86
cGMP: Generators, Effectors and Therapeutic Implications
Schmidt, H. H. H. W., Hofmann, F. B., & Stasch, J. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5 · Cited by 83
REGULATION OF NATRIURETIC PEPTIDE SECRETION BY THE HEART
Thibault, G., Amiri, F., & Garcia, R. (1999) · Annual Review of Physiology · doi:10.1146/annurev.physiol.61.1.193 · Cited by 83
Hayashi, D., Kudoh, S., Shiojima, I., Zou, Y., Harada, K., Shimoyama, M., Imai, Y., Monzen, K., Yamazaki, T., Yazaki, Y., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.119 · Cited by 78
Kohno, M., Yokokawa, K., Yasunari, K., Kano, H., Minami, M., Ueda, M., & Yoshikawa, J. (1997) · Circulation Research · doi:10.1161/01.res.81.4.585 · Cited by 75
Mueller, D., Schulze, C., Baumeister, H., Buck, F., & Richter, D. (1992) · Biochemistry · doi:10.1021/bi00160a026 · Cited by 74
McMurray, J. J. V., Pfeffer, M. A., Swedberg, K. B., & Dzau, V. J. (2004) · Circulation · doi:10.1161/01.cir.0000147274.83071.68 · Cited by 74
Neprilysin Inhibition for Heart Failure
McMurray, J. J. V., Packer, M., & Solomon, S. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1412654 · Cited by 72
Atrial natriuretic peptide (ANP) is a high‐affinity substrate for rat insulin‐degrading enzyme
Müller, D., Baumeister, H., Buck, F., & Richter, D. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16374.x · Cited by 72
Fielitz, J., Dendorfer, A., Pregla, R., Ehler, E., Zurbrügg, H. R., Bartúnek, J., Hetzer, R., & Regitz‐Zagrosek, V. (2002) · Circulation · doi:10.1161/hc0302.103593 · Cited by 68
Dickey, D. M., & Potter, L. R. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.03.013 · Cited by 63
Azizi, M., Accent]nard, J. D. M. A., Bissery, A., Guyene, T.-T., & Bura-Rivière, A. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00360107 · Cited by 60
C-type Natriuretic Peptide Ameliorates Monocrotaline-induced Pulmonary Hypertension in Rats
Itoh, T., Nagaya, N., Murakami, S., Fujii, T., Iwase, T., Ishibashi‐Ueda, H., Yutani, C., Yamagishi, M., Kimura, H., & Kangawa, K. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-455oc · Cited by 57
KIM, D., AIZAWA, T., WEI, H., Pi, X., Rybalkin, S. D., Berk, B. C., & YAN, C. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.10.013 · Cited by 56
Fujita, S., Shimojo, N., Terasaki, F., Otsuka, K., Hosotani, N., Kohda, Y., Tanaka, T., Nishioka, T., Yoshida, T., Hiroe, M., et al. (2012) · Heart and Vessels · doi:10.1007/s00380-012-0311-0 · Cited by 54
Witherow, F. N., Dawson, P., Ludlam, C. A., Fox, K. A. A., & Newby, D. E. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02061-2 · Cited by 54
Piedimonte, G., Nadel, J. A., Long, C. S., & Hoffman, J. I. E. (1994) · Circulation Research · doi:10.1161/01.res.75.4.770 · Cited by 53
Williams, B., Cockcroft, J. R., Kario, K., Zappe, D., Cardenas, P., Hester, A., Brunel, P., & Zhang, J. Y. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004254 · Cited by 52
B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues
Yandle, T. G., & Richards, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.07.004 · Cited by 50
C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice
Murakami, S., Nagaya, N., Itoh, T., Fujii, T., Iwase, T., Hamada, K., Kimura, H., & Kangawa, K. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00087.2004 · Cited by 48
Neprilysin Inhibition — A Novel Therapy for Heart Failure
Jessup, M. L. (2014) · New England Journal of Medicine · doi:10.1056/nejme1409898 · Cited by 48
Revisiting salt and water retention: new diuretics, aquaretics, and natriuretics
Costello‐Boerrigter, L. C., Boerrigter, G., & Burnett, J. C. J. (2003) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00181-5 · Cited by 47
Pitt, B., Chang, P., & Timmermans, P. B. M. W. M. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00878552 · Cited by 42
Mistry, N., Westheim, A. S., & Kjeldsen, S. E. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.5.575 · Cited by 39
Volpe, M., Lembo, G., Condorelli, G., LUCA, N. D., Lamenza, F., Indolfi, C., & Trimarco, B. (1990) · Circulation · doi:10.1161/01.cir.82.4.1214 · Cited by 39
Self-citation藤田, 修. (2013) · Medical Entomology and Zoology · Cited by 38
Erythropoietin and the heart: facts and perspectives
Mastromarino, V., Volpe, M., Musumeci, B., Autore, C., & Conti, E. (2010) · Clinical Science · doi:10.1042/cs20100305 · Cited by 37
Self-citationTrimarco, B., Lembo, G., LUCA, N. D., Volpe, M., Ricciardelli, B., Condorelli, G., Rosiello, G., & Condorelli, M. (1989) · Circulation · doi:10.1161/01.cir.80.4.883 · Cited by 32
Self-citationVolpe, M., LUCA, N. D., Bigazzi, M. C., Vecchione, F., Lembo, G., Condorelli, M., & Trimarco, B. (1988) · Circulation · doi:10.1161/01.cir.77.4.849 · Cited by 25
Self-citationM-Atrial Natriuretic Peptide: A Novel Antihypertensive Protein Therapy
McKie, P. M., Ichiki, T., & Burnett, J. C. J. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0244-5 · Cited by 24
ANP and urodilatin: who is who in the kidney.
Hirsch, J. R., Meyer, M., & Forssmann, W.-G. (2006) · PubMed · Cited by 23
Bae, E. H., Kwon, S., Lee, J., & Kim, S. W. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.05.005 · Cited by 22
Carotid baroreceptor unloading decreases plasma atrial natriuretic factor in hypertensive patients.
Volpe, M., Mele, A., LUCA, N. D., Golino, P., Bondiolotti, G., Camargo, M. J. F., Atlas, S. A., & Trimarco, B. (1986) · PubMed · Cited by 5
Self-citation
Cited by
Neurohormonal activation in heart failure with reduced ejection fraction
Hartupee, J., & Mann, D. L. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.163 · Cited by 709
Heart failure and kidney dysfunction: epidemiology, mechanisms and management
Schefold, J. C., Filippatos, G., Hasenfuss, G., Anker, S. D., & von Haehling, S. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.113 · Cited by 671
Arrigo, M., Jessup, M., Mullens, W., Reza, N., Shah, A. M., Sliwa, K., & Mebazaa, A. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0151-7 · Cited by 574
Pathophysiology of obesity and its associated diseases
Jin, X., Qiu, T., Li, L., Yu, R., Chen, X., Li, C., Proud, C. G., & Jiang, T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.012 · Cited by 499
Harjola, V.-P., Mullens, W., Banaszewski, M., Bauersachs, J., Brunner-La Rocca, H.-P., Chioncel, O., Collins, S. P., Doehner, W., Filippatos, G. S., Flammer, A. J., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.872 · Cited by 430
Metadata
- Authors
- Volpe, M., Carnovali, M., & Mastromarino, V.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2015-12-04
- Volume
- 130
- Issue
- 2
- Pages
- 57-77
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2195459026
- Cited by
- 305
- References
- 152
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.